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Regarding “Acute arterial complications associated
with total hip and knee arthroplasty”
We read with great interest the article by Calligaro et al (J Vasc
Surg 2003;38:1170-7) describing their experiences with acute
arterial complications related to hip and knee arthroplasty. We find
one major point of concern in their work. The authors stated that
“patients did not receive routinely anticoagulation therapy” after
urgent vascular surgery performed in those patients developing
signs of acute arterial complications shortly after arthroplasty.
Although the question of routine thromboprophylaxis after major
orthopedic surgery has been raised before1 and is also an issue of
debate in vascular surgery,2,3 current guidelines still recommend
some form of prophylaxis to be used in such patients. Since in
patients undergoing lower extremity arthroplasty, an intense acti-
vation of the clotting cascade4 is associated with venous stasis and
endothelial injury caused by kinking of the femoral vein during
intraoperative lower extremity manipulation, these patients are at
high risk for venous thromboembolism.5 The use of a tourniquet
during total knee arthroplasty is an additional risk factor. Subse-
quent vascular surgery can only heighten the risk for venous
thromboembolism in such patients.
Although thromboprophylaxis was not a focus of their work,
the authors should have clearly stated on what grounds they chose
to go against current guidelines and omit postoperative anticoag-
ulation in such high-risk patients. It should also have been noted
whether their patients received some other form of thrombopro-
phylaxis (eg, intermittent pneumatic compression) and how early
passive and active limb mobilization was begun. These are points
crucial to any patient undergoing total hip or knee arthroplasty.
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Reply
We appreciate the inquiry of Drs Oremus and Safaric. We did
not mean to imply that anticoagulation medications were not given
at all postoperatively following acute limb revascularization after
knee and hip surgery. We continued the routine postoperative
anticoagulation protocol used by the orthopedic service. However,
we did not add any additional or stronger anticoagulation medica-
tions such as a continuous heparin drip, which is occasionally
administered after other thrombectomy or revascularization pro-
cedures.
Keith D. Calligaro, MD
Pennsylvania Hospital
Philadelphia, Pa
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